Search by Drug Name or NDC
NDC 00003-0494-20 KENALOG-10 10 mg/mL Details
KENALOG-10 10 mg/mL
KENALOG-10 is a INTRA-ARTICULAR; INTRALESIONAL INJECTION, SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by E.R. Squibb & Sons, L.L.C.. The primary component is TRIAMCINOLONE ACETONIDE.
Product Information
| NDC | 00003-0494 |
|---|---|
| Product ID | 0003-0494_1df55c51-c951-4bf9-a8f2-174d3814cdfe |
| Associated GPIs | 22100050101805 |
| GCN Sequence Number | 006793 |
| GCN Sequence Number Description | triamcinolone acetonide VIAL 10 MG/ML INJECTION |
| HIC3 | P5A |
| HIC3 Description | GLUCOCORTICOIDS |
| GCN | 27450 |
| HICL Sequence Number | 002891 |
| HICL Sequence Number Description | TRIAMCINOLONE ACETONIDE |
| Brand/Generic | Brand |
| Proprietary Name | KENALOG-10 |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | TRIAMCINOLONE ACETONIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SUSPENSION |
| Route | INTRA-ARTICULAR; INTRALESIONAL |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/mL |
| Substance Name | TRIAMCINOLONE ACETONIDE |
| Labeler Name | E.R. Squibb & Sons, L.L.C. |
| Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA012041 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00003-0494-20 (00003049420)
| NDC Package Code | 0003-0494-20 |
|---|---|
| Billing NDC | 00003049420 |
| Package | 1 VIAL, MULTI-DOSE in 1 CARTON (0003-0494-20) / 5 mL in 1 VIAL, MULTI-DOSE |
| Marketing Start Date | 2009-06-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 2.3208 |
| Pricing Unit | ML |
| Effective Date | 2023-09-20 |
| NDC Description | KENALOG-10 50 MG/5 ML VIAL |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis